JP2014526924A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014526924A5 JP2014526924A5 JP2014522811A JP2014522811A JP2014526924A5 JP 2014526924 A5 JP2014526924 A5 JP 2014526924A5 JP 2014522811 A JP2014522811 A JP 2014522811A JP 2014522811 A JP2014522811 A JP 2014522811A JP 2014526924 A5 JP2014526924 A5 JP 2014526924A5
- Authority
- JP
- Japan
- Prior art keywords
- negative pressure
- pump
- bandage
- pressure source
- controller
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000012530 fluid Substances 0.000 claims description 69
- 230000000694 effects Effects 0.000 claims description 60
- 238000012544 monitoring process Methods 0.000 claims description 44
- 230000004044 response Effects 0.000 claims description 14
- 230000008859 change Effects 0.000 claims description 9
- 230000000007 visual effect Effects 0.000 claims description 6
- 230000003213 activating effect Effects 0.000 claims description 5
- 206010052428 Wound Diseases 0.000 description 293
- 208000027418 Wounds and injury Diseases 0.000 description 292
- 239000010410 layer Substances 0.000 description 137
- 230000007704 transition Effects 0.000 description 113
- 238000000034 method Methods 0.000 description 101
- 238000004806 packaging method and process Methods 0.000 description 79
- 239000000463 material Substances 0.000 description 58
- 230000001954 sterilising effect Effects 0.000 description 51
- 238000004659 sterilization and disinfection Methods 0.000 description 44
- 230000002745 absorbent Effects 0.000 description 42
- 239000002250 absorbent Substances 0.000 description 42
- 238000002560 therapeutic procedure Methods 0.000 description 42
- 239000007789 gas Substances 0.000 description 37
- 239000007788 liquid Substances 0.000 description 32
- 239000006260 foam Substances 0.000 description 21
- 230000002829 reductive effect Effects 0.000 description 19
- 210000000416 exudates and transudate Anatomy 0.000 description 17
- 230000004397 blinking Effects 0.000 description 16
- 239000000835 fiber Substances 0.000 description 14
- 230000008569 process Effects 0.000 description 12
- 238000010586 diagram Methods 0.000 description 11
- 238000005259 measurement Methods 0.000 description 10
- -1 sizes Substances 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 10
- 230000001052 transient effect Effects 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 230000009471 action Effects 0.000 description 9
- 239000000853 adhesive Substances 0.000 description 9
- 230000001070 adhesive effect Effects 0.000 description 9
- 238000004891 communication Methods 0.000 description 9
- 239000000945 filler Substances 0.000 description 9
- 230000007246 mechanism Effects 0.000 description 9
- 230000001580 bacterial effect Effects 0.000 description 8
- 239000002245 particle Substances 0.000 description 8
- 239000011148 porous material Substances 0.000 description 8
- 230000004888 barrier function Effects 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 230000007423 decrease Effects 0.000 description 7
- 239000010408 film Substances 0.000 description 7
- 230000035876 healing Effects 0.000 description 7
- 230000033001 locomotion Effects 0.000 description 7
- 238000003825 pressing Methods 0.000 description 7
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 6
- 230000005540 biological transmission Effects 0.000 description 6
- 239000000356 contaminant Substances 0.000 description 6
- 239000004744 fabric Substances 0.000 description 6
- 229920000728 polyester Polymers 0.000 description 6
- 229920002635 polyurethane Polymers 0.000 description 6
- 239000004814 polyurethane Substances 0.000 description 6
- 238000005070 sampling Methods 0.000 description 6
- 239000013464 silicone adhesive Substances 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 230000000670 limiting effect Effects 0.000 description 5
- 230000013011 mating Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 230000035699 permeability Effects 0.000 description 5
- 229920001296 polysiloxane Polymers 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 229920003043 Cellulose fiber Polymers 0.000 description 4
- 229910000831 Steel Inorganic materials 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 239000012633 leachable Substances 0.000 description 4
- 238000012423 maintenance Methods 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 230000000737 periodic effect Effects 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000008439 repair process Effects 0.000 description 4
- 125000006850 spacer group Chemical group 0.000 description 4
- 239000010959 steel Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 239000004698 Polyethylene Substances 0.000 description 3
- 239000004775 Tyvek Substances 0.000 description 3
- 229920000690 Tyvek Polymers 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 239000012298 atmosphere Substances 0.000 description 3
- 239000013039 cover film Substances 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000002572 peristaltic effect Effects 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 229920006264 polyurethane film Polymers 0.000 description 3
- 239000004800 polyvinyl chloride Substances 0.000 description 3
- 229920000915 polyvinyl chloride Polymers 0.000 description 3
- 238000005086 pumping Methods 0.000 description 3
- 230000029663 wound healing Effects 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 229920000858 Cyclodextrin Polymers 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 2
- 102000005741 Metalloproteases Human genes 0.000 description 2
- 108010006035 Metalloproteases Proteins 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 229920000297 Rayon Polymers 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- 208000002847 Surgical Wound Diseases 0.000 description 2
- 229910021536 Zeolite Inorganic materials 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- RHJVJSBJAPQUOS-UHFFFAOYSA-N [S].[Ag].C1=CC=NN=C1 Chemical compound [S].[Ag].C1=CC=NN=C1 RHJVJSBJAPQUOS-UHFFFAOYSA-N 0.000 description 2
- 239000003522 acrylic cement Substances 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000012790 adhesive layer Substances 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 2
- 238000004880 explosion Methods 0.000 description 2
- 230000037313 granulation tissue formation Effects 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 229960001680 ibuprofen Drugs 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 230000003434 inspiratory effect Effects 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000003771 matrix metalloproteinase inhibitor Substances 0.000 description 2
- 229940121386 matrix metalloproteinase inhibitor Drugs 0.000 description 2
- 238000009581 negative-pressure wound therapy Methods 0.000 description 2
- 239000004745 nonwoven fabric Substances 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 239000012466 permeate Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 230000005068 transpiration Effects 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 239000010457 zeolite Substances 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- WCMOHMXWOOBVMZ-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 6-[3-(2,5-dioxopyrrol-1-yl)propanoylamino]hexanoate Chemical compound O=C1CCC(=O)N1OC(=O)CCCCCNC(=O)CCN1C(=O)C=CC1=O WCMOHMXWOOBVMZ-UHFFFAOYSA-N 0.000 description 1
- GINVCSKBOCDMBE-UHFFFAOYSA-N 2-chloro-1h-hexazine Chemical compound ClN1NN=NN=N1 GINVCSKBOCDMBE-UHFFFAOYSA-N 0.000 description 1
- 229940123208 Biguanide Drugs 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 229920001634 Copolyester Polymers 0.000 description 1
- 229920001651 Cyanoacrylate Polymers 0.000 description 1
- 206010056340 Diabetic ulcer Diseases 0.000 description 1
- 229920006347 Elastollan Polymers 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 208000035874 Excoriation Diseases 0.000 description 1
- 229920002449 FKM Polymers 0.000 description 1
- 239000004831 Hot glue Substances 0.000 description 1
- 208000034693 Laceration Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 1
- 229920000459 Nitrile rubber Polymers 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- CYTYCFOTNPOANT-UHFFFAOYSA-N Perchloroethylene Chemical group ClC(Cl)=C(Cl)Cl CYTYCFOTNPOANT-UHFFFAOYSA-N 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 229920002413 Polyhexanide Polymers 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 229920001247 Reticulated foam Polymers 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 206010044546 Traumatic ulcer Diseases 0.000 description 1
- 208000000558 Varicose Ulcer Diseases 0.000 description 1
- 229920004482 WACKER® Polymers 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 239000011358 absorbing material Substances 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 238000001266 bandaging Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical group 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000009519 contusion Effects 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000023753 dehiscence Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 238000005108 dry cleaning Methods 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 239000013536 elastomeric material Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 239000013003 healing agent Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 239000012943 hotmelt Substances 0.000 description 1
- 239000000416 hydrocolloid Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 238000000608 laser ablation Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000004377 microelectronic Methods 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000002445 nipple Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000004172 nitrogen cycle Methods 0.000 description 1
- 239000012811 non-conductive material Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 229920001084 poly(chloroprene) Polymers 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920005644 polyethylene terephthalate glycol copolymer Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000007420 reactivation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000018040 scab formation Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000004092 self-diagnosis Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- SDKPSXWGRWWLKR-UHFFFAOYSA-M sodium;9,10-dioxoanthracene-1-sulfonate Chemical compound [Na+].O=C1C2=CC=CC=C2C(=O)C2=C1C=CC=C2S(=O)(=O)[O-] SDKPSXWGRWWLKR-UHFFFAOYSA-M 0.000 description 1
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000012414 sterilization procedure Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 229950011008 tetrachloroethylene Drugs 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161511950P | 2011-07-26 | 2011-07-26 | |
| US61/511,950 | 2011-07-26 | ||
| PCT/US2011/059016 WO2013015827A2 (en) | 2011-07-26 | 2011-11-02 | Systems and methods for controlling operation of a reduced pressure therapy system |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017080330A Division JP6714535B2 (ja) | 2011-07-26 | 2017-04-14 | 減圧治療システムの動作を制御するためのシステム及び方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014526924A JP2014526924A (ja) | 2014-10-09 |
| JP2014526924A5 true JP2014526924A5 (cg-RX-API-DMAC7.html) | 2014-12-25 |
| JP6131253B2 JP6131253B2 (ja) | 2017-05-17 |
Family
ID=47601703
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014522811A Active JP6131253B2 (ja) | 2011-07-26 | 2011-11-02 | 減圧治療システムの動作を制御するためのシステム及び方法 |
| JP2017080330A Active JP6714535B2 (ja) | 2011-07-26 | 2017-04-14 | 減圧治療システムの動作を制御するためのシステム及び方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017080330A Active JP6714535B2 (ja) | 2011-07-26 | 2017-04-14 | 減圧治療システムの動作を制御するためのシステム及び方法 |
Country Status (11)
| Country | Link |
|---|---|
| EP (2) | EP2736547B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP6131253B2 (cg-RX-API-DMAC7.html) |
| CN (3) | CN105749363B (cg-RX-API-DMAC7.html) |
| AU (2) | AU2011373654B2 (cg-RX-API-DMAC7.html) |
| BR (2) | BR122014027005A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2843133C (cg-RX-API-DMAC7.html) |
| ES (1) | ES2754252T3 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2014000998A (cg-RX-API-DMAC7.html) |
| RU (2) | RU2016132417A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2013015827A2 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA201400793B (cg-RX-API-DMAC7.html) |
Families Citing this family (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0808376D0 (en) | 2008-05-08 | 2008-06-18 | Bristol Myers Squibb Co | Wound dressing |
| GB0817796D0 (en) | 2008-09-29 | 2008-11-05 | Convatec Inc | wound dressing |
| GB201015656D0 (en) | 2010-09-20 | 2010-10-27 | Smith & Nephew | Pressure control apparatus |
| GB201020236D0 (en) | 2010-11-30 | 2011-01-12 | Convatec Technologies Inc | A composition for detecting biofilms on viable tissues |
| CN103347561B (zh) | 2010-12-08 | 2016-09-07 | 康沃特克科技公司 | 用于评估伤口分泌液的集成系统 |
| PL2648795T3 (pl) | 2010-12-08 | 2023-05-08 | Convatec Technologies Inc. | System do usuwania wysięków z miejsca rany |
| CN103347562B (zh) | 2010-12-08 | 2016-08-10 | 康沃特克科技公司 | 伤口分泌液系统附件 |
| GB201115182D0 (en) | 2011-09-02 | 2011-10-19 | Trio Healthcare Ltd | Skin contact material |
| US9084845B2 (en) | 2011-11-02 | 2015-07-21 | Smith & Nephew Plc | Reduced pressure therapy apparatuses and methods of using same |
| GB2497406A (en) | 2011-11-29 | 2013-06-12 | Webtec Converting Llc | Dressing with a perforated binder layer |
| GB201120693D0 (en) | 2011-12-01 | 2012-01-11 | Convatec Technologies Inc | Wound dressing for use in vacuum therapy |
| US9427505B2 (en) | 2012-05-15 | 2016-08-30 | Smith & Nephew Plc | Negative pressure wound therapy apparatus |
| JP2016507663A (ja) | 2012-12-20 | 2016-03-10 | コンバテック・テクノロジーズ・インコーポレイテッドＣｏｎｖａｔｅｃ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ | 化学修飾セルロース系繊維の加工 |
| EP3869515B1 (en) * | 2014-10-14 | 2024-08-21 | Solventum Intellectual Properties Company | System for monitoring compliant usage of negative pressure wound therapy |
| JP6725527B2 (ja) | 2014-12-22 | 2020-07-22 | スミス アンド ネフュー ピーエルシーＳｍｉｔｈ ＆ Ｎｅｐｈｅｗ Ｐｕｂｌｉｃ Ｌｉｍｉｔｅｄ Ｃｏｍｐａｎｙ | 陰圧閉鎖療法の装置および方法 |
| EP3297697B1 (en) | 2015-05-18 | 2022-05-11 | Smith & Nephew plc | Negative pressure wound therapy apparatus |
| JP2018529407A (ja) | 2015-08-13 | 2018-10-11 | スミス アンド ネフュー インコーポレイテッド | 陰圧治療をかけるためのシステム及び方法 |
| GB2543544A (en) | 2015-10-21 | 2017-04-26 | Brightwake Ltd | Wound dressing |
| JP1586115S (cg-RX-API-DMAC7.html) | 2016-02-29 | 2017-09-19 | ||
| CN109416355A (zh) | 2016-03-30 | 2019-03-01 | 定性酶诊断有限责任两合公司 | 检测伤口微生物感染 |
| US20190142642A1 (en) | 2016-03-30 | 2019-05-16 | Convatec Technologies Inc. | Detecting microbial infections in wounds |
| GB201608099D0 (en) | 2016-05-09 | 2016-06-22 | Convatec Technologies Inc | Negative pressure wound dressing |
| TWI595902B (zh) | 2016-05-10 | 2017-08-21 | 明基材料股份有限公司 | 攜帶型負壓裝置 |
| CN109475669B (zh) * | 2016-05-24 | 2022-01-04 | 苏马瓦克医疗解决方案公司 | 用于在手术后收集内部液体的带有一次性储存器的便携式设备 |
| CA3030151A1 (en) | 2016-07-08 | 2018-01-11 | Convatec Technologies Inc. | Fluid collection apparatus |
| MX2019000239A (es) | 2016-07-08 | 2019-09-06 | Convatec Technologies Inc | Sistema de presion negativa flexible. |
| TW201805035A (zh) | 2016-07-08 | 2018-02-16 | 美商康瓦鐵克科技股份有限公司 | 流體流動感測 |
| GB2586557B (en) * | 2016-08-12 | 2022-03-30 | Smith & Nephew Inc | Systems and methods for applying reduced pressure therapy |
| CA3035134A1 (en) * | 2016-08-31 | 2018-03-08 | Smith & Nephew Plc | Systems and methods for controlling operation of a reduced pressure therapy system to detect leaks |
| JP6926239B2 (ja) | 2017-02-15 | 2021-08-25 | スミス・アンド・ネフュー・アジア・パシフィク・ピーティーイー・リミテッド | 陰圧創傷治療装置およびその使用方法 |
| EP3687592B1 (en) | 2017-09-29 | 2025-09-03 | T.J. Smith & Nephew, Limited | Negative pressure wound therapy apparatus with removable panels |
| EP4360666A3 (en) | 2017-11-16 | 2024-05-08 | ConvaTec Limited | Fluid collection apparatus |
| GB201813282D0 (en) | 2018-08-15 | 2018-09-26 | Smith & Nephew | System for medical device activation and opertion |
| GB201804347D0 (en) | 2018-03-19 | 2018-05-02 | Smith & Nephew Inc | Securing control of settings of negative pressure wound therapy apparatuses and methods for using the same |
| GB201806988D0 (en) | 2018-04-30 | 2018-06-13 | Quintanar Felix Clarence | Power source charging for negative pressure wound therapy apparatus |
| GB201808438D0 (en) | 2018-05-23 | 2018-07-11 | Smith & Nephew | Systems and methods for determining blockages in a negative pressure wound therapy system |
| CN109731185A (zh) * | 2019-01-04 | 2019-05-10 | 沈阳林特医药科技有限公司 | 一种多针深度可控式电子注射器及其控制系统 |
| EP3930778A1 (en) * | 2019-02-28 | 2022-01-05 | KCI Licensing, Inc. | Negative pressure wound therapy leak alarm system |
| EP3962544B1 (en) | 2019-06-03 | 2023-11-08 | Convatec Limited | Methods and devices to disrupt and contain pathogens |
| WO2021059127A1 (en) * | 2019-09-24 | 2021-04-01 | Kci Licensing, Inc. | Apparatuses, systems, and methods for pump control in therapy devices |
| GB201914283D0 (en) | 2019-10-03 | 2019-11-20 | Smith & Nephew | Apparatuses and methods for negative pressure wound therapy |
| US11331221B2 (en) | 2019-12-27 | 2022-05-17 | Convatec Limited | Negative pressure wound dressing |
| US11771819B2 (en) | 2019-12-27 | 2023-10-03 | Convatec Limited | Low profile filter devices suitable for use in negative pressure wound therapy systems |
| GB202002338D0 (en) * | 2020-02-20 | 2020-04-08 | Convatec Ltd | A method and control system for a wound therapy apparatus |
| EP3915531B1 (en) | 2020-05-25 | 2024-05-01 | Mölnlycke Health Care AB | A negative pressure wound therapy (npwt) dressing |
| ES2984375T3 (es) | 2020-05-25 | 2024-10-29 | Moelnlycke Health Care Ab | Apósito para terapia de heridas con presión negativa (TPNP) |
| ES2983577T3 (es) | 2020-05-25 | 2024-10-23 | Moelnlycke Health Care Ab | Apósito de terapia de heridas por presión negativa (NPWT) |
| CN114469518B (zh) * | 2022-01-27 | 2023-02-21 | 长沙海润生物技术有限公司 | 负压电场耦合强氧治疗的敷料 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6458109B1 (en) * | 1998-08-07 | 2002-10-01 | Hill-Rom Services, Inc. | Wound treatment apparatus |
| JP2000300662A (ja) * | 1999-04-19 | 2000-10-31 | Sumitomo Bakelite Co Ltd | 電動式低圧持続吸引器 |
| US6764462B2 (en) * | 2000-11-29 | 2004-07-20 | Hill-Rom Services Inc. | Wound treatment apparatus |
| GB0224986D0 (en) | 2002-10-28 | 2002-12-04 | Smith & Nephew | Apparatus |
| GB0308197D0 (en) | 2003-04-09 | 2003-05-14 | The Technology Partnership Plc | Gas flow generator |
| GB0325129D0 (en) | 2003-10-28 | 2003-12-03 | Smith & Nephew | Apparatus in situ |
| GB0518826D0 (en) * | 2005-09-15 | 2005-10-26 | Smith & Nephew | Apparatus with actives from tissue - exudialysis |
| US7909805B2 (en) | 2004-04-05 | 2011-03-22 | Bluesky Medical Group Incorporated | Flexible reduced pressure treatment appliance |
| US8062272B2 (en) | 2004-05-21 | 2011-11-22 | Bluesky Medical Group Incorporated | Flexible reduced pressure treatment appliance |
| US7708724B2 (en) | 2004-04-05 | 2010-05-04 | Blue Sky Medical Group Incorporated | Reduced pressure wound cupping treatment system |
| GB0409446D0 (en) | 2004-04-28 | 2004-06-02 | Smith & Nephew | Apparatus |
| US20110077605A1 (en) * | 2005-07-14 | 2011-03-31 | Boehringer Technologies, L.P. | Pump system for negative pressure wound therapy |
| US7837673B2 (en) * | 2005-08-08 | 2010-11-23 | Innovative Therapies, Inc. | Wound irrigation device |
| CN101257938A (zh) * | 2005-09-07 | 2008-09-03 | 泰科保健集团有限合伙公司 | 具有真空储存器的伤口敷料 |
| WO2008039223A1 (en) * | 2006-09-26 | 2008-04-03 | Boehringer Technologies L.P. | Pump system for negative pressure wound therapy |
| ES2447296T3 (es) * | 2006-10-13 | 2014-03-11 | Bluesky Medical Group Incorporated | Control de presión de una bomba de vacío médica |
| MX2009008397A (es) * | 2007-02-09 | 2009-10-28 | Kci Licensing Inc | Sistema y metodo para administrar presion reducida en un sitio de tejido. |
| CA2675263C (en) * | 2007-02-20 | 2012-01-03 | Kci Licensing, Inc. | System and method for distinguishing leaks from a disengaged canister condition in a reduced pressure treatment system |
| RU70627U1 (ru) * | 2007-09-17 | 2008-02-10 | Вадим Владимирович Белов | Устройство для вакуумной терапии гнойных ран |
| GB0722820D0 (en) | 2007-11-21 | 2008-01-02 | Smith & Nephew | Vacuum assisted wound dressing |
| JP5613566B2 (ja) | 2007-11-21 | 2014-10-22 | スミス アンド ネフュー ピーエルシーＳｍｉｔｈ ＆ Ｎｅｐｈｅｗ Ｐｕｂｌｉｃ Ｌｉｍｉｔｅｄ Ｃｏｍｐａｎｙ | 創傷被覆材 |
| CA2705898C (en) | 2007-11-21 | 2020-08-25 | Smith & Nephew Plc | Wound dressing |
| GB0723855D0 (en) * | 2007-12-06 | 2008-01-16 | Smith & Nephew | Apparatus and method for wound volume measurement |
| US20100036367A1 (en) * | 2008-08-05 | 2010-02-11 | Bluesky Medical Group, Inc. | Wound overlay with cuff for wound treatment employing reduced pressure |
| EP2346545B2 (en) * | 2008-08-08 | 2022-06-08 | KCI Licensing, Inc. | Reduced-pressure treatment systems with reservoir control |
| US8827983B2 (en) * | 2008-08-21 | 2014-09-09 | Smith & Nephew, Inc. | Sensor with electrical contact protection for use in fluid collection canister and negative pressure wound therapy systems including same |
| US8646479B2 (en) | 2010-02-03 | 2014-02-11 | Kci Licensing, Inc. | Singulation of valves |
| GB201015656D0 (en) * | 2010-09-20 | 2010-10-27 | Smith & Nephew | Pressure control apparatus |
-
2011
- 2011-11-02 CN CN201610096127.7A patent/CN105749363B/zh active Active
- 2011-11-02 BR BR122014027005-4A patent/BR122014027005A2/pt not_active IP Right Cessation
- 2011-11-02 ES ES11869855T patent/ES2754252T3/es active Active
- 2011-11-02 CN CN201710217222.2A patent/CN107096076B/zh active Active
- 2011-11-02 EP EP11869855.4A patent/EP2736547B1/en active Active
- 2011-11-02 CN CN201180073693.1A patent/CN103987410B/zh active Active
- 2011-11-02 BR BR112014001884A patent/BR112014001884A2/pt not_active IP Right Cessation
- 2011-11-02 AU AU2011373654A patent/AU2011373654B2/en active Active
- 2011-11-02 WO PCT/US2011/059016 patent/WO2013015827A2/en not_active Ceased
- 2011-11-02 RU RU2016132417A patent/RU2016132417A/ru not_active Application Discontinuation
- 2011-11-02 RU RU2014106899/14A patent/RU2596728C2/ru not_active IP Right Cessation
- 2011-11-02 MX MX2014000998A patent/MX2014000998A/es unknown
- 2011-11-02 EP EP19188307.3A patent/EP3622976B1/en active Active
- 2011-11-02 JP JP2014522811A patent/JP6131253B2/ja active Active
- 2011-11-02 CA CA2843133A patent/CA2843133C/en active Active
-
2014
- 2014-02-03 ZA ZA2014/00793A patent/ZA201400793B/en unknown
-
2017
- 2017-04-14 JP JP2017080330A patent/JP6714535B2/ja active Active
- 2017-08-03 AU AU2017210588A patent/AU2017210588B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6131253B2 (ja) | 減圧治療システムの動作を制御するためのシステム及び方法 | |
| JP5897724B2 (ja) | 減圧治療装置及びその使用方法 | |
| US11648342B2 (en) | Reduced pressure therapy apparatuses and methods of using same | |
| US11623039B2 (en) | Systems and methods for controlling operation of a reduced pressure therapy system | |
| JP2014526924A5 (cg-RX-API-DMAC7.html) | ||
| JP2014532498A5 (cg-RX-API-DMAC7.html) | ||
| JP2016127998A (ja) | 減圧治療装置及びその使用方法 |